Company / Financials
CHINA PHARMA HOLDINGS, INC. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$4.1M
FY2025 · -40.9% YoY
Net Income
-$3.2M
FY2025 · -3.5% YoY
Profit Margin
-76.9%
FY2025 · net income / revenue
ROE
-14.0%
FY2025 · return on equity
Total Assets
$31.0M
FY2025
Total Debt
-
FY2025
Equity
$22.7M
FY2025
ROA
-10.3%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$4.1M-40.9% YoYNet Income HistoryProfit after all expenses and taxes-$3.2M-3.5% YoYGross Profit HistoryRevenue minus cost of goods sold-$131.9K+53.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$4.3M-41.4% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$3.2M-17.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$2.5M+67.2% YoYR&D Expense HistoryResearch and development spending$280.9K+17.0% YoYInterest Expense HistoryCost of borrowing and debt obligations$27.3K-10.8% YoYIncome Tax HistoryTotal income tax expense-EPS (Basic) HistoryBasic earnings per share-$2.71-197.8% YoY